Dear Inotiv, My name is Jong Ik Kwon, DVM , a graduate of Seoul National University College of Veterinary Medicine. Earlier in my career, I worked for Kwangdong Pharmaceutical as a Clinical Research Manager (CRM) for two years , where I gained direct experience in clinical development, regulatory processes, and pharmaceutical operations.Read more
Inotiv helps drug and medical device companies run early-stage testing, and growing demand for new medicines is pushing more of that work to outside specialists. If its newer tools and combined operations keep improving service and cutting waste, it could win more repeat business—but changing rules and pressure to replace animal testing could upend that outlook.Read more
Drug makers are spending more on early-stage research and leaning harder on outside partners, and Inotiv aims to ride that wave by expanding its testing and development services. The upside comes from smoother operations and a reputation for high animal-care standards, but shaky customer demand and a heavy debt load could still derail the story.Read more
Key Takeaways Shifting industry practices, high fixed costs, and integration risks threaten margin expansion and create uncertainty in revenue predictability and backlog conversion. Evolving alternatives to animal testing, rising debt costs, and client trends could undermine traditional revenue streams and weigh on future growth opportunities.Read more
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana. On June 3, 2026, Inotiv, Inc. along with its affiliates filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
